Amchafibrin
FPS-TRA-2017-02
Phase 3 small_molecule completed
Quick answer
Amchafibrin for Osteoarthritis, Knee is a Phase 3 program (small_molecule) at Lxo Ireland Designated Activity Company with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lxo Ireland Designated Activity Company
- Indication
- Osteoarthritis, Knee
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed